Trial NCT00915811

View at ClinicalTrials.gov 
Org. Study IDs: 06CC12
Secondary IDs: 2006-004452-20 REC - 06/Q0703/208

Last trial update was posted on 2011-08-17

MeSH Interventions

Antilymphocyte Serum Busulfan Fludarabine Thymoglobulin

MeSH Conditions

Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute Myelodysplastic Syndromes Preleukemia Syndrome

Other Conditions


Stopping Reasons

FB ATG is now a standard for sib allo MDS patients

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID